Overestimates of survival after HAART: implications for global scale-up efforts.

by Gregory P Bisson, Tendani Gaolathe, Robert Gross, Caitlin Rollins, Scarlett Bellamy, Mpho Mogorosi, Ava Avalos, Harvey Friedman, Diana Dickinson, Ian Frank, Ndwapi Ndwapi
Published 2008-03-01

Comparison of an in-house 'home-brew' and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples.

by Kaelo K Seatla, Wonderful T Choga, Mompati Mogwele, Thabo Diphoko, Dorcas Maruapula, Lucy Mupfumi, Rosemary M Musonda, Christopher F Rowley, Ava Avalos, Ishmael Kasvosve, Sikhulile Moyo, Simani Gaseitsiwe
Published 2019-01-01

Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis

by Dr. Mansour Farahani, MD, Anusha Vable, MHP, Refeletswe Lebelonyane, MD, Khumo Seipone, MD, Marina Anderson, MD, Ava Avalos, MD, Tim Chadborn, PhD, Hailu Tilahun, MSc, Danae Roumis, MSc, Themba Moeti, MBBS, Godfrey Musuka, DVM, Lesego Busang, MA, Tendani Gaolathe, MD, Kolaatamo C S Malefho, MD, Prof. Richard Marlink, MD
Published 2014-01-01